Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Olema Pharmaceuticals (OLMA) Return on Capital Employed (2021 - 2026)

Olema Pharmaceuticals (OLMA) has 6 years of Return on Capital Employed data on record, last reported at 41.62% in Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 630.0% to 41.62% in Q1 2026 year-over-year; TTM through Mar 2026 was 41.62%, a 630.0% decrease, with the full-year FY2025 number at 40.58%, up 358.0% from a year prior.
  • Return on Capital Employed reached 41.62% in Q1 2026 per OLMA's latest filing, up from 45.69% in the prior quarter.
  • Over the last five years, Return on Capital Employed for OLMA hit a ceiling of 28.68% in Q1 2022 and a floor of 64.21% in Q3 2024.
  • A 5-year average of 46.76% and a median of 45.69% in 2025 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: plummeted -3216bps in 2023, then soared 1590bps in 2024.
  • Tracing OLMA's Return on Capital Employed over 5 years: stood at 51.62% in 2022, then increased by 23bps to 39.87% in 2023, then fell by -19bps to 47.61% in 2024, then rose by 4bps to 45.69% in 2025, then increased by 9bps to 41.62% in 2026.
  • Business Quant data shows Return on Capital Employed for OLMA at 41.62% in Q1 2026, 45.69% in Q4 2025, and 50.8% in Q3 2025.